default author photo

Alasdair Bamford

University College London - Infection, Immunity and Inflammation Research & Teaching Department

SCHOLARLY PAPERS

4

DOWNLOADS

361

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Oral Valganciclovir Initiated Beyond One Month of Age for the Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection

Number of pages: 30 Posted: 03 Mar 2023
University of Alabama at Birmingham, University of Alabama at Birmingham, University of Alabama at Birmingham, University of Alabama at Birmingham, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, Newcastle Upon Tyne Hospitals NHS Foundation Trust, University College London - Infection, Immunity and Inflammation Research & Teaching Department, University College London - Infection, Immunity and Inflammation Research & Teaching Department, Children's National Hospital - Children's Research Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Southampton, The University of Manchester - Manchester University NHS Foundation Trust, University of Rochester, Levine Children's Hospital, St George’s University Hospitals NHS Foundation Trust, Baylor College of Medicine, Heartlands Hospital, Ohio State University (OSU) - Nationwide Children's Hospital, Sheffield Children’s Hospital, University of Oxford - Department of Paediatrics, Alpert Medical School of Brown University, University of Washington, University of Alabama at Birmingham and University College London
Downloads 153 (500,001)

Abstract:

Loading...

Congenital Cytomegalovirus, Valganciclovir, Antiviral, Hearing Loss, Sensorineural, Infant, Toddler, Audiology

2.

Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): a randomised, open-label, non-inferiority, 96-week trialevaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen (CAB/RPV) compared to daily oral therapy (DTG based TDF or TAF with 3TC or FTC backbone) in virologically suppressed adolescents living with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa

Number of pages: 34 Posted: 30 Oct 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, Joint Clinical Research Centre, Moi University, affiliation not provided to SSRN, Enhancing Care Foundation, University College London - MRC Clinical Trials Unit, Joint Clinical Research Centre, University of Zimbabwe - Clinical Trials Research Centre, Moi University, University of KwaZulu-Natal, Fondazione Penta ETS, affiliation not provided to SSRN, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Radboud University Medical Center, University of York, University College London - Infection, Immunity and Inflammation Research & Teaching Department, University College London - MRC Clinical Trials Unit, Baylor University - Children's Foundation Uganda, affiliation not provided to SSRN, University College London - MRC Clinical Trials Unit, affiliation not provided to SSRN, University College London - MRC Clinical Trials Unit, Baylor University - Children's Foundation Uganda and University College London - MRC Clinical Trials Unit
Downloads 78 (830,555)

Abstract:

Loading...

HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial

3.

Short-Cycle Therapy (Weekends-Off) on Dolutegravir-Based Antiretroviral Therapy in Adolescents Living with HIV (BREATHER Plus): A Randomised, Open-Label, 96-Week Non-Inferiority Trial

Number of pages: 29 Posted: 10 Sep 2025
Baylor University - Children's Foundation Uganda, University College London - MRC Clinical Trials Unit, University of Zimbabwe - Clinical Trials Research Centre, Joint Clinical Research Centre, Moi University, University of KwaZulu-Natal, University College London - MRC Clinical Trials Unit, Fondazione Penta ETS, Baylor University - Children's Foundation Uganda, University of Zimbabwe, Joint Clinical Research Centre, Moi University, Enhancing Care Foundation, London School of Hygiene & Tropical Medicine - Department of Global Health and Development, Joint Clinical Research Centre, Baylor University - Children's Foundation Uganda, University of York, Radboud University Nijmegen - Radboud University Medical Center, University of Padua - Department of Women’s and Children’s Health, Baylor University - Children's Foundation Uganda, University of Zimbabwe, Moi University, Enhancing Care Foundation, Fondazione Penta ETS, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University College London - Infection, Immunity and Inflammation Research & Teaching Department, University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit and University College London - MRC Clinical Trials Unit
Downloads 75 (852,604)

Abstract:

Loading...

HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial

4.

Weight Gain, Body Composition and Metabolic Parameters on Dolutegravir-Based Antiretroviral Therapy Versus Standard of Care in Children and Adolescents: A Secondary Analysis of the ODYSSEY Trial

Number of pages: 30 Posted: 11 Sep 2025
University College London - MRC Clinical Trials Unit, University College London - MRC Clinical Trials Unit, University of the Witwatersrand - Perinatal HIV Research Unit, Department of Paediatrics, University of Zimbabwe, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Mbarara, Joint Clinical Research Centre, Mahasarakam Hospital, Makerere University - Johns Hopkins University Research Collaboration, University of the Witwatersrand - Department of Internal Medicine, University of KwaZulu-Natal, Stellenbosch University, Chulalongkorn University - Center of Excellence in Pediatric Infectious Diseases and Vaccines, University of Zimbabwe, Baylor University - Children's Foundation Uganda, Joint Clinical Research Centre, Chris Hani Baragwanath Academic Hospital, Goethe University, University Hospitals Birmingham NHS Foundation Trust, Research on AIDS and Viral Hepatitis (ANRS), University College London - Infection, Immunity and Inflammation Research & Teaching Department, Chiang Mai University, Makerere University - Johns Hopkins University Research Collaboration, Joint Clinical Research Centre, London School of Hygiene & Tropical Medicine - Department of Clinical Research, University of Padua - Department of Women’s and Children’s Health, University of Padua, University College London - MRC Clinical Trials Unit and University College London - MRC Clinical Trials Unit
Downloads 55 (1,041,696)

Abstract:

Loading...

HIV, children, adolescents, dolutegravir, weight-gain, body fat percentage, lipid profile, glycaemia